Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib-Reference-Cited by-同舟云学术

Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib

Published:2013-10-01 Issue:5 Volume:58 Page:1655-1666
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Vouche Michael¹,Kulik Laura²,Atassi Rohi¹,Memon Khairuddin¹,Hickey Ryan¹,Ganger Daniel²,Miller Frank H.¹,Yaghmai Vahid¹,Abecassis Michael³,Baker Talia³,Mulcahy Mary⁴,Nayar Ritu⁵,Lewandowski Robert J.¹,Salem Riad¹³⁴

Affiliation:

1. Department of Radiology; Section of Interventional Radiology and Division of Interventional Oncology; Northwestern University; Chicago IL

2. Department of Medicine; Division of Hepatology; Northwestern University; Chicago IL

3. Department of Surgery; Division of Transplantation; Northwestern University; Chicago IL

4. Department of Medicine; Division of Medical Oncology; Northwestern University; Chicago IL

5. Department of Surgical Pathology; Northwestern University; Chicago IL

Funder

National Instututes of Health

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26487/fullpdf

Reference27 articles.

1. Design and endpoints of clinical trials in hepatocellular carcinoma;Llovet;J Natl Cancer Inst,2008

2. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

3. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma;Lencioni;Semin Liver Dis,2010

4. Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation;Riaz;J Hepatol,2011

5. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres;Riaz;Hepatology,2009

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma;Acta Radiologica;2023-02-26

2. Procedural technique development;Translational Interventional Radiology;2023

3. TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis;Cancer Medicine;2022-08-09

4. Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology;European Radiology;2022-04-05

5. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study;International Journal of Hyperthermia;2022-01-18